11 results match your criteria: "Clinical Investigation Center 1414[Affiliation]"
Therapie
July 2024
Université de Rennes, CHU de Rennes, Inserm, EHESP, Institut de recherche en santé, environnement et travail (Irset), UMR S 1085, 35000 Rennes, France; Inserm, Clinical Investigation Center 1414, 35000 Rennes, France; FHU SUPORT, 35000 Rennes, France.
Nirmatrelvir/ritonavir is a protease inhibitor antiviral drug indicated in the treatment of severe acute respiratory syndrome coronavirus-2 infections in high-risk patients for a severe disease. Unfortunately, ritonavir, used to boost nirmatrelvir pharmacokinetics, can also inhibit or induce the metabolism of other co-administered drugs substrates. This may lead to a subsequent risk of adverse drug reaction and lack of efficacy.
View Article and Find Full Text PDFRev Neurol (Paris)
April 2024
Epilepsy Unit, Reference Center for Rare Epilepsies, Neurology Department, Clinical Investigation Center 1414, Rennes University Hospital, Rennes, France; Signal and Image Processing Laboratory (LTSI), INSERM, Rennes University, Rennes, France. Electronic address:
The ILAE's Task Force on Nosology and Definitions revised in 2022 its definition of juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy disorder, but this definition may well change again in the future. Although good drug response could almost be a diagnostic criterion for JME, drug resistance (DR) is observed in up to a third of patients. It is important to distinguish this from pseudoresistance, which is often linked to psychosocial problems or psychiatric comorbidities.
View Article and Find Full Text PDFFEBS Open Bio
July 2023
Inserm, UMR_S 1242, OSS (Oncogenesis Stress Signaling), Centre de Lutte contre le Cancer Eugène Marquis, Univ Rennes, France.
Therapeutic targeting of the transforming growth factor beta (TGFβ) pathway in cancer represents a clinical challenge since TGFβ exhibits either tumor suppressive or tumor promoting properties, depending on the tumor stage. Thus, treatment with galunisertib, a small molecule inhibitor of TGFβ receptor type 1, demonstrated clinical benefits only in subsets of patients. Due to the functional duality of TGFβ in cancer, one can hypothesize that inhibiting this pathway could result in beneficial or adverse effects depending on tumor subtypes.
View Article and Find Full Text PDFCirculation
October 2022
NuMeCan (Nutrition, Metabolism and Cancer) Insitute. EXPRES (Exogenous and endogenous stress, plasticity of responses and diseases) Team. Mixed Research Unit 1241 INSERM (National Institute of Health and Medical Research), Rennes University Hospital, F-35033, Rennes, France. Vascular Medicine Department, Clinical Investigation Center 1414, Rennes University Hospital, F-35033, Rennes, France. Vascular Medicine Unit, Redon Hospital, F-35600, Redon, France. ODYSSEY Research For A Better Life Non-Profit Organization, F-97410, Saint-Pierre, La Reunion, France.
Ann Surg
November 2022
Department of Hepato-Biliary and Digestive Surgery, Rennes University Hospital France.
Objective: The aim of the study was to evaluate the impact of the use of a reinforced stapler (RS) during distal pancreatectomy (DP) on postoperative outcomes.
Background: DP remains associated with significant postoperative morbidity owing to pancreatic fistula (PF). To date, there is no consensus on the management of the pancreatic stump.
Int J Mol Sci
August 2021
Pôle Hospitalo-Universitaire de Psychiatrie de l'Enfant et de l'Adolescent (PHUPEA), Centre Hospitalier Guillaume Régnier, University of Rennes 1, 35000 Rennes, France.
Clin Immunol
July 2020
Vascular Medicine Unit, Inserm, (Clinical Investigation Center 1414), Univ Rennes, CHU Rennes, Rennes F-35033, France.
Clin Immunol
July 2020
Inserm, Clinical Investigation Center 1414, Univ Rennes, CHU Rennes, Rennes F-35033, France.
Mult Scler Relat Disord
May 2020
SPHERE (methodS in Patient-centered outcomes & HEalth ResEarch) U1246, INSERM, Nantes University, Tours University, Nantes, France; Nantes University Hospital, Nantes, France. Electronic address:
Background: One of the main challenges in multiple sclerosis (MS) is to predict disease progression based on patient characteristics and therapeutic strategies. We therefore performed a systematic review to critically appraise the composite tools available for this purpose.
Methods: We performed electronic database searches in MEDLINE, EMBASE, Web of Science and the Cochrane Library.
Allergol Int
April 2019
AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et d'Allergologie Pédiatriques, Paris, France; Université Paris Descartes, Paris, France. Electronic address:
Blood
March 2017
University of Virginia Cancer Center, Charlottesville, VA.
Large granular lymphocyte (LGL) leukemia has been recognized by the World Health Organization classifications amongst mature T-cell and natural killer (NK) cell neoplasms. There are 3 categories: chronic T-cell leukemia and NK-cell lymphocytosis, which are similarly indolent diseases characterized by cytopenias and autoimmune conditions as opposed to aggressive NK-cell LGL leukemia. Clonal LGL expansion arise from chronic antigenic stimulation, which promotes dysregulation of apoptosis, mainly due to constitutive activation of survival pathways including Jak/Stat, MapK, phosphatidylinositol 3-kinase-Akt, Ras-Raf-1, MEK1/extracellular signal-regulated kinase, sphingolipid, and nuclear factor-κB.
View Article and Find Full Text PDF